Literature DB >> 21944835

Overweight is a risk factor for both erosive and non-erosive reflux disease.

Edoardo Savarino1, Patrizia Zentilin, Elisa Marabotto, Daria Bonfanti, Simona Inferrera, Lorenzo Assandri, Giorgio Sammito, Lorenzo Gemignani, Manuele Furnari, Pietro Dulbecco, Vincenzo Savarino.   

Abstract

INTRODUCTION: Studies have reported that the association between overweight and erosive oesophagitis is very strong, whilst seeming less consistent with non-erosive reflux disease. AIM: We have hypothesized that this difference may be due to the heterogeneity of endoscopy-negative population.
METHODS: We studied 81 patients with erosive oesophagitis, 48 controls and 295 endoscopy-negative patients classified by impedance-pH-testing as: (1) pH-POS (abnormal acid exposure); (2) hypersensitive oesophagus (normal acid exposure/SAP+); (3) functional heartburn (normal acid exposure/SAP-). Body mass index was also calculated.
RESULTS: Mean body mass index was significantly higher (p<0.05) in erosive oesophagitis than in endoscopy-negative patients as a whole and controls [27 (18-40) vs. 25 (16-48) vs. 23 (16-34)]. However, the separation of endoscopy-negative patients showed that mean body mass index was higher (p<0.05) in those with increased acid exposure time [26 (18-45)] than in hypersensitive oesophagus [24 (16-48)]. The former subgroup was similar to erosive oesophagitis, whilst the latter one to both functional heartburn [23 (16-34)] and controls (p=ns). Increased body mass index represented a risk factor for erosive oesophagitis (odds ratio 1.4; 95% confidence interval, 1.2-1.6) and non-erosive reflux disease pH-POS subgroup (odds ratio 1.35; 95% confidence interval, 1.2-1.5).
CONCLUSION: Our study shows that overweight represents an important risk factor for erosive oesophagitis and pH-POS non-erosive reflux disease and not for hypersensitive oesophagus and functional heartburn. This provides an explanation for the previously reported lesser role of this variable in non-erosive reflux disease population. Copyright Â
© 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21944835     DOI: 10.1016/j.dld.2011.07.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  20 in total

1.  Non-erosive reflux disease patients are more complex than the sole endoscopy tells us.

Authors:  Andrea Ottonello; Vincenzo Savarino; Edoardo Savarino
Journal:  Clin Oral Investig       Date:  2013-08-09       Impact factor: 3.573

2.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

Review 3.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

4.  Sleeve Gastrectomy, GERD, and Barrett's Esophagus: It Is Time for Objective Testing.

Authors:  Salvatore Tolone; Edoardo Savarino; Nicola De Bortoli; Ludovico Docimo
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

5.  The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders.

Authors:  Edoardo Savarino; Chiara De Cassan; Giorgia Bodini; Manuele Furnari; Nicola de Bortoli; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2014-06-28       Impact factor: 7.527

6.  Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Authors:  Edoardo Savarino; Patrizia Zentilin; Radu Tutuian; Daniel Pohl; Lorenzo Gemignani; Alberto Malesci; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

7.  Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.

Authors:  Yasuhiro Tamura; Yasushi Funaki; Shinya Izawa; Akihito Iida; Yoshiharu Yamaguchi; Kazunori Adachi; Naotaka Ogasawara; Makoto Sasaki; Hiroshi Kaneko; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

8.  Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study.

Authors:  Alberto Zalar; Baya Haddouche; Michel Antonietti; Raied Alhameedi; Isabelle Iwanicki-Caron; Stéphane Lecleire; Philippe Ducrotté
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

9.  Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.

Authors:  Nicola de Bortoli; Leonardo Frazzoni; Edoardo V Savarino; Marzio Frazzoni; Irene Martinucci; Aleksandra Jania; Salvatore Tolone; Michele Scagliarini; Massimo Bellini; Elisa Marabotto; Manuele Furnari; Giorgia Bodini; Salvatore Russo; Lorenzo Bertani; Veronica Natali; Lorenzo Fuccio; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

10.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.